BPC-157 + TB-500
The Wolverine stack: one daily shot for a stubborn injury, when BPC alone is not enough and it hurts in more than one place.
What it is
This is the pair people reach for when a tendon, joint or muscle has been sore for months and plain rest has not fixed it. BPC-157 works hardest at one spot and on the gut; TB-500 spreads the repair signal through the whole body, so you do not have to inject at the exact site.
Who actually runs this: someone with a shoulder that has clicked for a year, a hamstring that keeps re-tearing, a wrist and a knee at the same time, or a surgery coming up and a recovery they want to shorten. If you have one small sore spot and nothing else, plain BPC-157 injected near it is cheaper and enough. The stack earns its price when the problem is spread out, deep, or old.
The timeline: the first thing most people notice, around day 5 to 10, is that the sore spot is less angry in the morning and warms up faster. Real structural change, like a tendon that stops flaring after a hard session, takes three to six weeks. Good looks like being able to train the thing again by week four without the next-day payback. It is not a painkiller, so day one feels like nothing, and it will not fix a full tear that needs surgery.
How it is run: for a cruise, about 1 mg a day total, 0.5 mg of each, one subQ shot anywhere with a little fat, usually the belly. For an acute injury or around surgery, people push it to 5 mg a day, split morning and evening, for a few weeks, then drop back. There are anecdotes of up to 10 mg a day for an acute injury with results that scaled with the dose. The biggest mistake, same as with BPC alone, is underdosing: 250 mcg of each for two weeks and deciding it does nothing. The second is quitting in week two, before anything structural has had time to happen. Neither half is known to stop working with steady use, so there is no reason to stop mid-repair for a scheduled break; once the injury settles, stop or drop to a few shots a week.
The honest evidence read: both halves rest on strong animal data (tendon, ligament, muscle and gut healing in rodents, over and over) and very little in people. The pair has never been trialed together. So the realistic bet is what each half does alone, BPC-157's tendon and gut results plus TB-500's looser joints, delivered in one shot; nobody has measured any extra synergy.
When it is not worth it: a fresh minor strain that will heal in two weeks on its own, or a gut-only problem, where BPC-157 alone does the job. If skin and collagen are part of what you want, the GHK-Cu + BPC-157 blend covers that instead, though its copper caps the dose. There is no copper here, which is exactly why you can run this one high and often for a short, aggressive push. Pricey at the acute tier; the usual comparison is a cortisone shot, which quiets pain fast but can weaken the tendon.
What people use it for
Tendons, ligaments and muscle
Some evidenceBPC-157 has repeatedly sped tendon-to-bone and ligament healing in rodents, and TB-500's parent protein (thymosin beta-4) drives cell migration into damaged tissue in animal wound models. Human data is case reports and clinic experience, not trials. In practice this is the best-supported use of the pair.
Injuries in more than one place
Some evidenceTB-500 is small enough to circulate and act body-wide, which is why people with a shoulder and a knee at the same time choose the stack over local BPC shots. The systemic reach is well shown in animals; the convenience is the real-world reason it is popular.
Gut lining and inflammation
Some evidenceBPC-157 was isolated from gastric juice and has a long rodent record for ulcer and gut-lining repair, which carries over into the stack. If the gut is your only target, BPC alone is enough; the stack adds TB-500 for the musculoskeletal side.
The two together
Early daysNo study has tested BPC-157 and TB-500 as a pair. The case for combining them is that they work by different routes, local repair and angiogenesis from BPC, cell migration and body-wide signaling from TB-500, so they should add rather than overlap. That is reasoning plus a lot of user reports, not a trial.
What's inside
How it works
- Pairs local repair (BPC-157) with body-wide repair (TB-500)
- Each peptide has its own animal research; the combination is not separately trialed
- Human evidence is very limited for both, so it stays promising, not proven
- A popular recovery stack, but worth a doctor conversation first
How people use it
Safety, in brief
Things people sometimes notice
- Tiredness in the first week or two, which usually lifts
- A small sore bump where you inject, worse if you inject cold solution
- Mild head pressure for some people in the first days
The full picture — stop signs and who should talk to a doctor first — is on the dosing guide.
Sources
This blend's research is on each compound's own page, with its sources: